Anti-Epileptics and Anti-Depressants Flashcards
ethosuximide
absence seizure; block T-type Ca channels in the thalamus, preventing spike-wave; side fx: fatigue, GI, headache
phenytoin
partial and TC; prolong refractory period of voltage-gated Na channels in a use-dependent manner; 1st order –> 0 order metabolism; drug interactions, gingival hyperplasia, excessive hair growth
carbamezipine
partial and TC; prolong refractory period of voltage-gated Na channels in a use-dependent manner; + mood effects
gabapentin
partial and TC; alpha-2-delta Ca channels
valproaic acid
all seizures; mechanism unclear; + mood effects; side fx: GI, liver, pancreas; TERATOGEN
lamotrigine
all seizures, prolong refractory period of voltage-gated Na channels; side fx: rash (10% SJS)
levetiracetam
all seizures; SV2A synaptic vesicle protein
lorazepam
status epilepticus; increase GABAnergic neuron, short-acting; side fx: sedation, tolerance, dependence
diazepam
status epilepticus; increase GABAnergic neuron activity, long-acting; side fx: sedation, tolerance, dependence
non-pharmalogical therapies
1) ketogenic diet 2) surgical resection (focal seizures) 3) vagus nerve stimulator 4) deep brain stimulator (anterior nucleus of the thalamus) 5) response neurostimulator
fluoxetine
SSRI (non-pure), long half-life, active metabolite, CYP2D6 inhibitor, aka Prozac
sertraline
SSRI (non-pure), aka Zoloft
citalopram
SSRI (pure)
escitalopram
SSRI (pure)
duloxetine
balanced combination NE and serotonin reuptake inhibitor
venlafaxine
primarily SSRI at low dose, becomes SNRI at high dose, comes in IR/XR side fx: high BP
mirtazapine
5-HT2A receptor blocker; side fx: weight gain, sedation
buproprion
NDRI, can be used for smoking cessation, side fx: increased seizure risk, irritability
phenelzine
MAOI, drug interaction w/ SSRI, meperidine (HTN crisis)
tranylcypromine
MAOI, drug interaction w/ SSRI, meperidine (HTN crisis)
serotonergic side effects
sexual dysfunction, sleep disturbance, GI upset
noradrenergic side effects
tachycardia, tremor, constipation, dry mouth
dopaminergic side effects
psychomotor activation
tricyclic antidepressants
NRI